Aigen Investment Management, LP Bio Techne Corp Transaction History

Aigen Investment Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $1.19 Million - $1.43 Million	16,549 Added 75.21%	38,553 $2.86 Million
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $1.22 Million - $5.32 Million	15,094 Added 218.44%	22,004 $1.82 Million
Q3 2022 Nov 09, 2022	BUY	$282.54 - $391.85 $1.95 Million - $2.71 Million	6,910 New	6,910 $1.96 Million
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $196,600 - $226,300	-431 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $191,738 - $232,257	431 New	431 $209,000
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $520,712 - $678,823	-2,109 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$232.22 - $282.96 $489,751 - $596,762	2,109 New	2,109 $522,000
Q2 2020 Aug 10, 2020	SELL	$185.43 - $279.56 $40,423 - $60,944	-218 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$161.17 - $221.51 $33,039 - $45,409	205 Added 1576.92%	218 $41,000
Q4 2019 Feb 04, 2020	BUY	$189.68 - $222.09 $2,465 - $2,887	13 New	13 $3,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.